Indication
In combination with other antiretroviral medicinal products, for the treatment of adults infected with human immunodeficiency virus 1 (HIV-1) without past or present evidence of resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class.
Medicine details
- Medicine name:
- doravirine (Pifeltro)
- SMC ID:
- SMC2332
- Pharmaceutical company
- Merck Sharp & Dohme Ltd
- BNF chapter
- Infections
- Submission type
- Abbreviated
- Publication due date:
- 08 March 2021